Pacific Edge Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PFGTF research report →
About the company
Established in 2001 and headquartered in Dunedin, New Zealand, Pacific Edge Limited is a cancer diagnostics company dedicated to inventing, developing, and commercializing diagnostic and prognostic tools. These tools are designed for the early detection and effective management of various cancers, with the company's reach extending across New Zealand, the United States, Australia, and Singapore. Its operations are divided into two main segments: Commercial and Research.
- CEO
- Peter Meintjes
- IPO
- 2016
- Employees
- 114
- HQ
- Dunedin, NZ
Price Chart
- Market Cap
- $212.31M
- P/E
- -7.70
- P/S
- 23.84
- P/B
- 28.30
- EV/EBITDA
- -7.66
- Div Yield
- 0.00%
- Gross Margin
- -0.93%
- Op Margin
- -329.05%
- Net Margin
- -311.14%
- ROE
- -190.54%
- ROIC
- -304.32%
- Revenue
- $11.61M · -46.84%
- Net Income
- $-36,136,633 · -20.71%
- EPS
- $-0.04 · -3.51%
- Op Income
- $-38,217,284
- FCF YoY
- -24.46%
- 52W High
- $0.23
- 52W Low
- $0.02
- 50D MA
- $0.14
- 200D MA
- $0.12
- Beta
- 0.84
- Avg Volume
- 419
Get TickerSpark's AI analysis on PFGTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PFGTF coverage
Recent articles, reports, and earnings notes.
No research on PFGTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PFGTF report →Similar companies
Peers in the same neighborhood.